An announcement from BioNexus Gene Lab Corp (BGLC) is now available.
BioNexus Gene Lab Corp. has strategically invested RM 1 million to acquire a significant stake in Ascension Innovation Sdn Bhd, a Malaysian company specializing in AI healthcare solutions. This move is set to boost BioNexus’s market reach in genomic screening by leveraging Ascension’s digital health platforms, creating synergies that promise to enhance patient care and aid healthcare providers. The collaboration underscores BioNexus’s commitment to advancing in the digital health sector.
Find detailed analytics on BGLC stock on TipRanks’ Stock Analysis page.